Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 201

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Mesenchymal stromal cells alone or expressing interferon-β suppress pancreatic tumors in vivo, an effect countered by anti-inflammatory treatment

Kidd, Shannon, Caldwell, Lisa, Dietrich, Martin, Samudio, Ismael, Spaeth, Erika L, Watson, Keri, Shi, Yuexi, Abbruzzese, James, Konopleva, Marina, Andreeff, Michael, Marini, Frank C·2010·Cytotherapy
DOI 10.3109/14653241003631815
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3109/14653241003631815

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Research works printed but not linked: 45

  1. Jemal, 2008, Cancer statistics, 2008. CA Cancer, J Clin, 58, 71
  2. Chu, 2007, Stromal biology of pancreatic cancer, J Cell Biochem, 101, 887, 10.1002/jcb.21209 · DOI · Paper page
  3. Studeny, 2004, Mesenchymal stem cells: potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents, J Natl Cancer Inst, 96, 1593, 10.1093/jnci/djh299 · DOI · Paper page
  4. Studeny, 2002, Bone marrow-derived mesenchymal stem cells as vehicles for interferon-beta delivery into tumors, Cancer Res, 62, 3603
  5. Studeny, 2001, Bone marrow derived mesenchymal stem cells serve as precursors for stromal fibroblasts in malignant tumors and show potential for cancer therapy, Blood, 98, 697a
  6. Nakamizo, 2005, Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas, Cancer Res, 65, 3307, 10.1158/0008-5472.CAN-04-1874 · DOI · Paper page
  7. Jaster, 2004, Molecular regulation of pancreatic stellate cell function, Mol Cancer, 3, 26, 10.1186/1476-4598-3-26 · DOI
  8. Bachem, 1998, Identification, culture, and characterization of pancreatic stellate cells in rats and humans, Gastroenterology, 115, 421, 10.1016/S0016-5085(98)70209-4 · DOI · Paper page
  9. Li, 2000, Intrastriatal transplantation of bone marrow nonhematopoietic cells improves functional recovery after stroke in adult mice, J Cereb Blood Flow Metab, 20, 1311, 10.1097/00004647-200009000-00006 · DOI · Paper page
  10. Coussens, 2002, Inflammation and cancer, Nature, 420, 860, 10.1038/nature01322 · DOI · Paper page
  11. Bissell, 2001, Putting tumours in context, Nat Rev Cancer, 1, 46, 10.1038/35094059 · DOI · Paper page
  12. Honda, 1998, Design and synthesis of 2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid, a novel and highly active inhibitor of nitric oxide production in mouse macrophages, Bioorg Med Chem Lett, 8, 2711, 10.1016/S0960-894X(98)00479-X · DOI · Paper page
  13. Suh, 1999, A novel synthetic oleanane triterpenoid, 2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid, with potent differentiating, antiproliferative, and anti-inflammatory activity, Cancer Res, 59, 336
  14. Konopleva, 2006, Synthetic triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid induces growth arrest in HER2-overexpressing breast cancer cells, Mol Cancer Ther, 5, 317, 10.1158/1535-7163.MCT-05-0350 · DOI
  15. Liby, 2005, The synthetic triterpenoids, CDDO and CDDO- imidazolide, are potent inducers of heme oxygenase-1 and Nrf2/ARE signaling, Cancer Res, 65, 4789, 10.1158/0008-5472.CAN-04-4539 · DOI · Paper page
  16. Dezube, 2007, Interim results of a phase I trial with a novel orally administered synthetic triterpenoid RTA 402 (CDDO-Me) in patients with solid tumors and lymphoid malignancies. ASCO Annual Meeting Proceedings Part I, J Clin Oncol, 25, 14101, 10.1200/jco.2007.25.18_suppl.14101 · DOI
  17. Ling, 2007, The novel triterpenoid C-28 methyl ester of 2-cyano-3, 12-dioxoolen-1, 9-dien-28-oic acid inhibits metastatic murine breast tumor growth through inactivation of STAT3 signaling, Cancer Res, 67, 4210, 10.1158/0008-5472.CAN-06-3629 · DOI
  18. Kidd, 2009, Direct evidence of mesenchymal stem cell tropism for tumor and wounding microenvironments using in vivo bioluminescence imaging, Stem Cells, 27, 2614, 10.1002/stem.187 · DOI · Paper page
  19. Place, 2003, The novel synthetic triterpenoid, CDDO-imidazolide, inhibits inflammatory response and tumor growth in vivo, Clin Cancer Res, 9, 2798
  20. Samudio, 2005, 2-Cyano-3,12-dioxooleana-1,9-dien-28- imidazolide (CDDO-Im) directly targets mitochondrial glutathione to induce apoptosis in pancreatic cancer, J Biol Chem, 280, 36273, 10.1074/jbc.M507518200 · DOI
  21. Binger, 2009, Migration potential and gene expression profile of human mesenchymal stem cells induced by CCL25, Exp Cell Res, 315, 1468, 10.1016/j.yexcr.2008.12.022 · DOI
  22. Wang, 2002, MCP-1, MIP-1, IL-8 and ischemic cerebral tissue enhance human bone marrow stromal cell migration in interface culture, Hematology, 7, 113, 10.1080/10245330290028588 · DOI · Paper page
  23. Beckermann, 2008, VEGF expression by mesenchymal stem cells contributes to angiogenesis in pancreatic carcinoma, Br J Cancer, 99, 622, 10.1038/sj.bjc.6604508 · DOI · Paper page
  24. Udani, 2005, Hematopoietic stem cells give rise to perivascular endothelial-like cells during brain tumor angiogenesis, Stem Cells Dev, 14, 478, 10.1089/scd.2005.14.478 · DOI
  25. De Palma, 2003, Targeting exogenous genes to tumor angiogenesis by transplantation of genetically modified hematopoietic stem cells, Nat Med, 9, 789, 10.1038/nm871 · DOI · Paper page
  26. Lewis, 2006, Distinct role of macrophages in different tumor microenvironments, Cancer Res, 66, 605, 10.1158/0008-5472.CAN-05-4005 · DOI · Paper page
  27. Sato, 2005, Epidermal growth factor receptor-transfected bone marrow stromal cells exhibit enhanced migratory response and therapeutic potential against murine brain tumors, Cancer Gene Ther, 12, 757, 10.1038/sj.cgt.7700827 · DOI
  28. Li, 2005, Antileukemic effect of interleukin-7-transduced bone marrow stromal cells in mice following allogeneic T-cell-depleted bone marrow transplantation, Transplant Proc, 37, 2297, 10.1016/j.transproceed.2005.03.088 · doi:10.1016/j.transproceed.2005.03.088
  29. Kyriakou, 2006, Human mesenchymal stem cells (hMSCs) expressing truncated soluble vascular endothelial growth factor receptor (tsFlk-1) following lentiviral-mediated gene transfer inhibit growth of Burkitt's lymphoma in a murine model, J Gene Med, 8, 253, 10.1002/jgm.840 · DOI
  30. Karnoub, 2007, Mesenchymal stem cells within tumour stroma promote breast cancer metastasis, Nature, 449, 557, 10.1038/nature06188 · DOI · Paper page
  31. Maestroni, 1999, Factor(s) from nonmacrophage bone marrow stromal cells inhibit Lewis lung carcinoma and B16 melanoma growth in mice, Cell Mol Life Sci, 55, 663, 10.1007/s000180050322 · DOI
  32. Ohlsson, 2003, Mesenchymal progenitor cell-mediated inhibition of tumor growth in vivo and in vitro in gelatin matrix, Exp Mol Pathol, 75, 248, 10.1016/j.yexmp.2003.06.001 · DOI · Paper page
  33. Jiang, 2008, Inoculation of murine bone marrow mesenchymal stem cells induces tumor necrosis in mouse with orthotopic hepatocellular carcinoma, Beijing Da Xue Xue Bao, 40, 453
  34. Ganta, 2009, Rat umbilical cord stem cells completely abolish rat mammary carcinomas with no evidence of metastasis or recurrence 100 days post-tumor cell inoculation, Cancer Res, 69, 1815, 10.1158/0008-5472.CAN-08-2750 · DOI
  35. Cousin, 2009, Adult stromal cells derived from human adipose tissue provoke pancreatic cancer cell death both in vitro and in vivo, PLoS ONE, 4, e6278, 10.1371/journal.pone.0006278 · DOI · Paper page
  36. Wu, 2003, Migration of mesenchymal stem cells to heart allografts during chronic rejection, Transplantation, 75, 679, 10.1097/01.TP.0000048488.35010.95 · DOI · Paper page
  37. Li, 2006, Adult bone-marrow-derived mesenchymal stem cells contribute to wound healing of skin appendages, Cell Tissue Res, 326, 725, 10.1007/s00441-006-0270-9 · DOI · Paper page
  38. Klopp, 2007, Tumor irradiation increases the recruitment of circulating mesenchymal stem cells into the tumor microenvironment, Cancer Res, 67, 11687, 10.1158/0008-5472.CAN-07-1406 · DOI · Paper page
  39. Wang, 2002, MCP-1, MIP-1, IL-8 and ischemic cerebral tissue enhance human bone marrow stromal cell migration in interface culture, Hematology, 7, 113, 10.1080/10245330290028588 · DOI · Paper page
  40. Schichor, 2006, Vascular endothelial growth factor A contributes to glioma-induced migration of human marrow stromal cells (hMSC), Exp Neurol, 199, 301, 10.1016/j.expneurol.2005.11.027 · DOI
  41. Kress, 2007, Triterpenoids display single agent anti-tumor activity in a transgenic mouse model of chronic lymphocytic leukemia and small B cell lymphoma, PLoS ONE, 2, e559, 10.1371/journal.pone.0000559 · DOI
  42. Ling, 2007, The novel triterpenoid C-28 methyl ester of 2-cyano-3, 12-dioxoolen-1, 9-dien-28-oic acid inhibits metastatic murine breast tumor growth through inactivation of STAT3 signaling, Cancer Res, 67, 4210, 10.1158/0008-5472.CAN-06-3629 · DOI
  43. Konopleva, 2004, The synthetic triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid induces caspase-dependent and -independent apoptosis in acute myelogenous leukemia, Cancer Res, 64, 7927, 10.1158/0008-5472.CAN-03-2402 · DOI
  44. Mishra, 2008, Carcinoma-associated fibroblast-like differentiation of human mesenchymal stem cells, Cancer Res, 68, 4331, 10.1158/0008-5472.CAN-08-0943 · DOI · Paper page
  45. Spaeth, 2009, Mesenchymal stem cell transition to tumor-associated fibroblasts contributes to fibrovascular network expansion and tumor progression, PLoS ONE, 4, e4992, 10.1371/journal.pone.0004992 · DOI · Paper page

Cited by

See all 201

Metadata

Authors
Kidd, S., Caldwell, L., Dietrich, M., Samudio, I., Spaeth, E. L., Watson, K., Shi, Y., Abbruzzese, J., Konopleva, M., Andreeff, M., & Marini, F. C.
Venue
Cytotherapy
Publisher
Elsevier BV
Published
2010-09
Volume
12
Issue
5
Pages
615-625
ISSN
1465-3249 (ISSN-L)
DOI
10.3109/14653241003631815
OpenAlex
W2018872714
Cited by
201
References
10
FWCI
8.81
Type
journal article
Language
en
Open access
closed
Licence
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
  • www.elsevier.com/legal/tdmrep-license (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Mesenchymal stromal cells alone or expressing interferon-β suppress pancreatic tumors in vivo, an effect countered by anti-inflammatory treatment. https://app.cochat.ai/papers/10.3109/14653241003631815
The paper
Kidd, S., Caldwell, L., Dietrich, M., Samudio, I., Spaeth, E. L., Watson, K., Shi, Y., Abbruzzese, J., Konopleva, M., Andreeff, M., & Marini, F. C. (2010). Mesenchymal stromal cells alone or expressing interferon-β suppress pancreatic tumors in vivo, an effect countered by anti-inflammatory treatment. Cytotherapy. https://doi.org/10.3109/14653241003631815

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.